Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Schering AG patents fluorinated compounds that inhibit NOS

July 3, 2000

Preliminary data indicate potential of NPS-1776 as therapy for neurological disorders

July 3, 2000

Potential new opioid analgesics designed by AstraZeneca

July 3, 2000

New inhibitor of Abeta production emerges from collaborative Scios-DuPont research

July 3, 2000

Novel Vernalis compounds combine antioxidant and iron-chelating activity

June 30, 2000

Late-stage anxiolytic candidate dropped from Welfide development pipeline

June 30, 2000

Experimental study suggests potential of CP-0597 in the management of spinal cord injury

June 30, 2000

Two new EP1 receptor antagonists under development at Ono for pain and cancer

June 30, 2000

Receptor linked to sensitivity to inflammatory pain

June 30, 2000

Process of neurodegeneration linked to calpain activation

June 30, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...